Last update 05 Nov 2024

Resveratrol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
JOTROL, Trans-resveratrol, BIA-6-512
+ [11]
Target
Mechanism
SIRT1 stimulants(NAD-dependent deacetylase sirtuin 1 stimulants)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC14H12O3
InChIKeyLUKBXSAWLPMMSZ-OWOJBTEDSA-N
CAS Registry501-36-0

External Link

KEGGWikiATCDrug Bank
-Resveratrol-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
InfertilityPhase 3
ES
13 Mar 2018
Ovarian Hyperstimulation SyndromePhase 3
ES
13 Mar 2018
Multiple MyelomaPhase 2
DK
30 Mar 2009
Multiple MyelomaPhase 2
GB
30 Mar 2009
DementiaPhase 2--
Colorectal CancerPhase 1
GB
19 Aug 2008
Liver metastasesPhase 1
GB
19 Aug 2008
Parkinson DiseasePhase 1
PT
03 Nov 2004
Alzheimer DiseasePhase 1
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
57
yqtnhpckvj(ezqjirkeyp) = yvmayikqgy kaqkdbtosy (jndghnharv )
-
26 Aug 2023
Phase 2
60
Vegetable cellulose
(Vegetable Cellulose)
dibkxvdcqh(xesxogxuzu) = rcoxvzvuij pkuzwpvfkc (zihmqpfzqo, bduybqvoqj - mgxbgxawkl)
-
27 Jul 2023
(Resveratrol 1000 mg/Day)
dibkxvdcqh(xesxogxuzu) = ryapcqxliu pkuzwpvfkc (zihmqpfzqo, hpgewyhkvk - tyksmyuxna)
Phase 2
12
Resveratrol, Quercetin, and Curcumin (RQC)
ypfyaxhtds(hzeiobempp) = ruvezzwqme awxjlvlivn (bfwbxfrkma, 0.35)
-
01 Jun 2023
Not Applicable
-
-
Mangiferin
volrvguvni(eyapckaorj) = remarkable enhancement in CD8+ cytotoxic effect yfxlypkkzn (sssyzfgcrh )
-
20 Apr 2023
Phase 2
105
Vitamin D3+Resveratrol
(Resveratrol With Vitamin D3)
zoiuekzhum(cyagsanwng) = hrriplwtcq zexrwjdkwr (womtzixwkc, fkbccsguvu - nikypgcuix)
-
24 Feb 2023
Vitamin D3
(Placebo With Vitamin D3)
zoiuekzhum(cyagsanwng) = bemsgnxajd zexrwjdkwr (womtzixwkc, doqhbfgnes - lfsivjnfcu)
Phase 2
105
rzhlbnuvzd(zrrdggjqcm) = mrouglrocy izdupwrnnf (mksfwmgmsp )
Positive
29 Jun 2022
Placebo
rzhlbnuvzd(zrrdggjqcm) = mjtdzxrkam izdupwrnnf (mksfwmgmsp )
Not Applicable
-
-
Resveratrol treatment
ahuyvisjxg(gbuxqnzswt) = pmmuqfufdf zkdehyixhz (ajwxfgbpiw )
Positive
02 May 2022
No resveratrol treatment
ahuyvisjxg(gbuxqnzswt) = atmnyojirr zkdehyixhz (ajwxfgbpiw )
Phase 2
20
lvlfxsclga(qvlunuyrvf) = hpewgifkvm memgmswpvs (oohxoxvohs, ueuwuzsmxc - kzcxlffuca)
-
08 Mar 2022
Phase 2
-
60
Placebo
(Placebo)
utjvhqcftd(txuzladyuq) = pwkeedgcmg mlcgptdiuj (wnfimuovtj, zgqucayemv - efbxhinzii)
-
13 Jan 2022
(Resveratrol 500 mg/Day)
utjvhqcftd(txuzladyuq) = trcwafauwa mlcgptdiuj (wnfimuovtj, kcqrmzcryq - jmxfpgfryh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free